This study aims to understand the long-term effectiveness and safety of the HIV medication ibalizumab in real-world patients. It will compare health outcomes between 168 adults with multi-drug resistant HIV who receive ibalizumab and similar patients who do not. The goal is to se…
Sponsor: Theratechnologies • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC